Home Applications 215793 Application 215793
Type NDA
Sponsor UROGEN PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZUSDURI MITOMYCIN POWDER;INTRAVESICAL 40MG/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215793-001 ZUSDURI MITOMYCIN 40MG/VIAL POWDER / INTRAVESICAL RLD, RS 2025-06-12
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215793-001 10039832 2031-01-20 U-4256 2025-09-03 N215793-001 12440568 2031-01-20 U-4256 2025-10-21 N215793-001 9040074 2031-01-20 U-4256 Drug product 2025-09-03 N215793-001 9950069 2031-01-20 U-4256 Drug product 2025-09-03
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215793-001 NP 2028-06-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215793-001 ZUSDURI 40MG/VIAL POWDER / INTRAVESICAL RLD, RS 2025-06-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 ZUSDURI 40MG/VIAL POWDER / INTRAVESICAL RLD, RS 2025-06-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215793-001 ZUSDURI 40MG/VIAL POWDER / INTRAVESICAL RLD, RS 2025-06-12 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 ZUSDURI 40MG/VIAL POWDER / INTRAVESICAL RLD, RS 2025-06-12 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215793-001 10039832 2031-01-20 U-4256 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215793-001 12440568 2031-01-20 U-4256 2025-10-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215793-001 9040074 2031-01-20 U-4256 Drug product 2025-09-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215793-001 9950069 2031-01-20 U-4256 Drug product 2025-09-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 10039832 2031-01-20 U-4256 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 12440568 2031-01-20 U-4256 2025-10-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 9040074 2031-01-20 U-4256 Drug product 2025-09-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 9950069 2031-01-20 U-4256 Drug product 2025-09-03 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 10039832 2031-01-20 U-4256 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 12440568 2031-01-20 U-4256 2025-10-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 9040074 2031-01-20 U-4256 Drug product 2025-09-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 9950069 2031-01-20 U-4256 Drug product 2025-09-03 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215793-001 NP 2028-06-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215793-001 NP 2028-06-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215793-001 NP 2028-06-12 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215793-001 NP 2028-06-12 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZUSDURI MITOMYCIN UroGen Pharma, Inc 8dc68793-bca8-4e3d-b672-622961b58255 2025-06-20 Warnings, Adverse reactions Exact identifier application applno (NDA): 215793 application number: NDA215793
Documents# Document, Submission type, Date table Document Submission type Date 82574 ORIG 2025-06-13 82567 ORIG 2025-06-13